• Apr. 19, 2019 (PDF/113KB)Finances

  Sumitomo Dainippon Pharma Revises Financial Forecasts

• Apr. 19, 2019Finances

  Posted Video of Mid-term Business Plan 2022 [Webcast]

• Apr. 11, 2019 (PDF/2,177KB)Finances

  Presentation Material (Mid-term Business Plan 2022)

• Apr. 11, 2019 (PDF/83KB)Finances

  Sumitomo Dainippon Pharma Announces Mid-term Business Plan 2022(FY2018 - FY2022)

• Apr. 09, 2019 (PDF/167KB)R&D

  Poxel and Sumitomo Dainippon Pharma Announce Positive Top-Line Results for Imeglimin Phase 3 Trial (TIMES 1) in Japan for the Treatment of Type 2 Diabetes

more